The Food and Drug Administration (FDA) recently gave approval for clinical trials in the U.S. of a COVID-19 nasal vaccine ...

Hyderabad-based Bharat Biotech Ltd announced the launch of its oral cholera vaccine (OCV) Hillchol. This vaccine was ...

A single dose of Bharat Biotech’s intranasal vaccine iNCOVACC, which has been approved for inclusion into India’s Covid-19 immunisation programme, will cost Rs 800 each plus 5 percent Goods ...

A nasal vaccine for COVID-19 - based on technology developed at Washington University in St. Louis - is poised to enter a ...

Hyderabad: Vaccine maker Bharat Biotech invested Rs 1,500 crore in setting up what is touted as one of the world's largest vaccine manufacturing facilities at the Odisha Biotech Park in Bhubaneswar.

India's drug regulator has approved Zydus Cadila's three-dose COVID-19 DNA vaccine for emergency use ... 印度本土生产的Covishield，印度Bharat Biotech研发的新冠疫苗Covaxin ...

A version of the vaccine has been available in India since 2022 through a licensing agreement between WashU and the Indian biotechnology company Bharat Biotech. The Phase 1 trial is funded through ...

Save your favourite. The recent studies highlight notable adverse events globally caused by COVID-19 vaccines, regardless of the technology and manufacturer. Bharat Biotech has emphasised the need ...

Dr. Krishna Ella, co-founder and Executive Chairman of Bharat Biotech International, one of India’s leading vaccine makers, was earlier this week conferred with the India Fellowship of the ...

Dr. Singh urged states to establish ‘BioE3 Cells’ in collaboration with the Centre through the Department of Biotechnology (DBT).

Dr Krishna Ella, co-founder of Bharat Biotech, has been awarded the prestigious INSA India fellowship for 2025 for his significant contributions to vaccine technology and biotechnology.

The plant is expected to have the capacity to produce eight billion doses of vaccines per annum. Shanmugaratnam visited Sapigen Biologix (a subsidiary of Bharat Biotech) at its state-of-the-art ...